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Abstract: The current study aimed to investigate, for the first time, the beneficial effects of
3,5-dihydroxy-4′,7-dimethoxyflavone isolated from Tamarix aphylla L. against liver injury in mice.
Liver injury was induced by intraperitoneal (i.p.) injection of carbon tetrachloride (CCl4) at a dose of
0.4 mL/kg mixed in olive oil at ratio (1:4) twice a week for 6 consecutive weeks. The administration of
CCl4 caused significant histopathological changes in liver tissues while the pre-treatment with the
flavone at dose of 10 and 25 mg/kg ameliorated the observed liver damages. Also, it markedly reduced
hepatic malondialdehyde (MDA) level as well as increased the activities of liver superoxide dismutase
(SOD), catalase (CAT), and glutathione peroxidase (Gpx) compared with their recorded levels in
CCl4 model group. Moreover, the immunohistochemical analysis demonstrated the enhancement
in the protein level of B-cell lymphoma-2 (Bcl-2) while the protein levels of cysteine-aspartic acid
protease-3 (caspase-3), Bcl-2-associated x protein (Bax), transforming growth factor-β1 (TGF-β1) and
CD31 were suppressed following the flavone treatement. These results suggest that the flavone can
inhibit liver injury induced in mice owning to its impact on the oxidation, apoptotic and angiogenesis
mechanisms. Further pharmacological investigations are essential to determine the effectiveness of
the flavone in human.
Keywords: liver injury; CCl4; Tamarix aphylla; oxidative stress; apoptosis; angiogenesis
1. Introduction
The liver plays an essential role in some of the vital body functions including protein synthesis,
detoxification, and the metabolism of various consumed or absorbed substances [1–3]. Hence, the liver
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is the detoxification factory and the most exposed to the ingested and injected chemicals and drugs [1];
therefore, the excessive exposure to toxic or hazardous substances could induce liver injury on the
long run, affecting the life quality and health status [4]. Carbon tetrachloride (CCl4), is a solvent, and
a potent hepatotoxic agent that is widely used in animal models for induction of liver damage [5].
Its mechanism of action started at the hepatocytes where the activation of cytochrome P450 enzyme
produces trichloromethyl and trichloromethyl peroxide free radicals. These free radicals tightly bind
to the phospholipid molecules of the cell membranes, endoplasmic reticulum, and mitochondria,
causing lipid peroxidation, oxidative stress and the release of byproducts that block the intracellular
proteins and DNA [6,7]. The reactive aldehydes that produced as byproducts of lipid peroxidation
subsequently damage the structure and function of the cellular and intercellular membranes, resulting
in hepatotoxicity and carcinogenicity [8].
Superoxide dismutase (SOD) possess an antioxidant effect against superoxide radicals in
cells [9]. Catalase (CAT) neutralizes the harmful effects of peroxide radicals in biological systems [10].
Glutathione peroxidase (GPx) is an active scavenger of peroxides in cells [11]. Oxidative stress-induced
tissue damage is defined as the imbalance between oxidation and anti-oxidation generating burdened
free radicals and reducing the anti-oxidant capacity [12]. Apoptosis, similarly is the programmed
cell death that could be attributed to oxidative stress and accumulation of free radicals. Apoptosis
is the main cell death mechanism recognized following the induction of CCl4 liver injury [13,14].
Consequently, anti-oxidant and anti-apoptosis therapies exhibited desirable effects for prevention or
treatment of liver diseases in animal models [15,16].
Flavonoids are secondary plant metabolites responsible for colour and aroma of flowers. They
interfere with multiple signal transduction pathways involved in liver diseases leading to inhibition
of oxidative stress, apoptosis, and angiogenesis [17]. A natural flavonoid puerarin attenuated
CCl4-induced hepatotoxicity by reducing ROS production, restoring the antioxidant enzyme system
and regulating hepatic lipid biosynthesis level [18]. Also, quercetin protected liver from CCl4-induced
injury via antioxidative stress and anti-inflammation through inhibition of Toll-like receptor 2
(TLR2) and Toll-like receptor 4 (TLR4) activations and mitogen-activated protein kinase (MAPK)
phosphorylation [19]. A marine polyphenol, dieckol, mediated apoptosis-regulating genes via
downregulation of Bax and upregulation of Bcl-xl protein expressions [20]. Eupafolin blocked vascular
endothelial growth factor (VEGF) in human umbilical vascular endothelial cells and inhibited Akt
activity and VEGF secretion in HepG2 [21]. Morusin, inhibited angiogenesis via attenuation of the
IL-6 and activation of transcription 3 (STAT3) signalling pathway in mice bearing HepG2 cells [22].
Resveratrol exhibited effects on suppressing angiogenesis in mice with hepatocellular carcinoma (HCC)
xenograft through inhibiting VEGF expression by a NF-κB-mediated pathway [23].
Tamarix aphylla L. is an evergreen tree belongs to tamaricaceae family that is distributed
worldwide [24–26]. T. aphylla possessed anti-oxidant activity [27] owned to its content of different
flavonoids [28] and phenolics [29] with potential effects in prevention and treatment of many
diseases [30–32]. As part of our ongoing research to identify a new effective and functional natural
component [33–36] with high availability and low cost, the present study aims to investigate the
anti-oxidant, anti-apoptotic, and anti-proliferative activities of 3,5-dihydroxy-4′,7-dimethoxyflavone
(Figure 1) isolated from T. aphylla. The long-term goal is to develop a potent pharmaceutical agent
that inhibits the production and activation of free radicals and acts against CCl4-induced liver injury
in mice.
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Figure 1. Chemical structure of 3,5-dihydroxy-4′,7-dimethoxyflavone.
2. Results
2.1. Chemical Elucidation of the Flavone
The structure of the compound was established by chemical and spectral analysis, mainly MS, UV
and 1H-NMR. 3,5-Dihydroxy-7,4′-dimethoxyflavone: Yellow, amorphous powder; UV (MeOH) λmax
nm: 211, 233, 269, 327, 368; IR (KBr) νmax 3314, 2922, 2848, 1836, 1743, 1657, 1596, 1507, 1463, 1355,
1318, 1258, 1220, 1162, 1033 cm-1; 1H-NMR (CDCl3, 300 MHz): δ 11.71 (1H, s, H-O-5), 8.14 (2H, d, J= 9.0
Hz, H-2′ and H-6′), 7.01 (2H, d, J= 9.0 Hz, H-3′ and H-5′), 6.58 (1H, s, H-O-3), 6.46 (1H, d, J= 2.1 Hz,
H-8), 6.35 (1H, d, J= 2.1 Hz, H-6), 3.87 (3H, s, H3CO-7), 3.86 (3H, s, H3CO-4′). 13C-NMR (CD3OD, 300
MHz): δ 175.2 (C-4), 165.7 (C-7), 161.1 (C-4′), 160.8 (C-5), 156.8 (C-9), 145.7 (C-2), 135.7 (C-3), 129.4
(C-2′ and C-6′), 123.2 (C-1′), 114.1 (C-3′ and C-5′), 103.9 (C-10), 97.9 (C-6), 92.2 (C-8), 55.8 (CH3O-7),
55.4 (CH3O-4′). HREI-MS: m/z 314.078 calculated for C17 H14 O6 (Calcd. 314.079).
2.2. Histopathological Analysis of the Liver Tissues
Histopathological analysis of the liver tissues from the studied groups was illustrated in Figure 2.
In Figure 2A, the histopathological examination of the liver tissues of normal control mice showed
normal hepatocytes arranged in cords around the central vein and separated with blood sinusoids. The
hepatocytes have oval cytoplasm and vesicular-shaped nucleus. On the other hand, the liver tissues of
mice treated with CCl4 showed multiple histopathological changes manifested by the infiltration of
mononuclear inflammatory cells mainly macrophage and lymphocytes mixed with multiple neoplastic
cells and seen as multifocal granuloma like lesions within the whole hepatic parenchyma similar
to ehrlich ascites carcinoma cells (EACs). The infiltrative inflammatory cells were also noticed in
periportal area and within blood sinusoids. The findings as illustrated in Figure 2B showed swollen
hepatocytes with diffuse vacuolation and granular disrupted cytoplasm.
The pretreatment with flavone (10 mg/kg) protected the hepatocytes and remarkable decrease in
the number of focal infiltrative cells in particular neoplastic cells was demonstrated. The congested
areas showed mostly an increase in the necrobiotic changes and migration of the histocytes (Figure 2C).
However, the vacuolation was still noticed within the hepatic parenchyma as the hepatocytes showed
presence of clear round cytoplasmic vacuoles, the mice treated with 25 mg/kg flavone showed no or
minimum vacuolation. In addition, the degeneration foci were greatly diminished and small number
of mononuclear inflammatory cells were seen as illustrated in Figure 2D.
2.3. Markers of Oxidative Stress in Liver Tissue Homogenates
MDA is the commonly used indicator for lipid peroxidation. Therefore, the levels of MDA in the
liver homogenates were measured as in Figure 3. The levels of MDA in liver homogenates increased
significantly (p < 0.001) in CCl4 model group compared to the control group. The treatment with
flavone, especially high dose, exhibited a significant (p < 0.01) decrease in MDA production compared
to CCl4 model group (Figure 3).
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Figure 2. Histopathological graphs of liver sections stained by hematoxylin and eosin (H&E). (A):
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(p < 0.001) diminished the level of anti-oxidant enzymes in the liver tissue homogenate. Conversely,
the flavone treatment, especially the high dose, induced a significant increase in SOD, CAT, and Gpx
expression compared to the CCl4 model group (Table 1).
Table 1. Effect of the flavone on the levels of SOD, CAT, and Gpx in liver tissue homogenates.
Mice Group SOD(U/g Tissue)
CAT
(U/g Tissue)
Gpx
(U/g Tissue)
Normal control 1.23 ± 0.03 2.69 ± 0.01 38.74 ± 3.61
CCl4 model group 0.32 ± 0.07 ### 1.98 ± 0.23 ### 21.76 ± 4.01 ##
Flavone (10 mg/kg) 0.58 ± 0.02* 2.27 ± 0.03** 27.65 ± 2.35*
Flavone (25 mg/kg) 0.89 ± 0.07** 2.48 ± 0.29** 30 ± 1.63*
Data are presented as mean ± SD. Significantly (## p < 0.01, ### p < 0.001) different from normal control group.
Significantly (* p < 0.05, ** p < 0.01, *** p < 0.001) different from CCl4 model group. SOD: superoxide dismutase;
CAT: catalase; Gpx: glutathione peroxidase.
2.4. Apoptosis Regulators in Liver Tissue
As displayed in Figure 4, the administration of CCl4 caused a significant (p < 0.01) elevation in
caspase-3 levels compared to the control group. Treatment with flavone restored the protein levels of
caspase-3 compared to CCl4 group. In particular, the high dose of the flavone (25 mg/kg) significantly
(p < 0.01) decreased the level of caspase-3 to level near to the control group.
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group, c: CCl4 + flavone (10 mg/kg) group, d: CCl4 + flavone (25 mg/kg) group); (a) showed a noticeable
expression of caspase-3 immunostaining in the liver tissues (arrow). (b) presented marked increase
in caspase-3 expression within the liver tissues (arrow). (c) displayed mild to moderate decrease
of caspase-3 expression in the liver tissues (arrow). (d) illustrated an obvious decrease in caspase-3
expression within the liver tissues (arrow). Scale bar = 100 µm. (B): Statistical analysis of caspase-3
H-score. Data are expressed as mean ± SD. Significantly (## p < 0.01) different to negative control group.
Significantly (** p < 0.01) different to the CCl4 group.
Compared to the levels of the control group, the Bax level was significantly (p < 0.001) increased
in liver tissues after CCl4 injection. In contrast, Bax levels declined in mice injected with CCl4 and
treated with flavone. A high dose of the flavone significantly (p < 0.001) decreased Bax levels, with an
effect stronger than that observed in the other groups (Figure 5).
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c: CCl4 + flavone (10 mg/kg) group, d: CCl4 + flavone (25 mg/kg) group); (a) showed a noticeable
expression of Bax immunostaining in the liver tissues (arrow). (b) presented marked increase in Bax
expression within the liver tissues (arrow). (c) displayed mild to moderate decrease of caspase-3
expression in the liver tissues (arrow). (d) illustrated an obvious decrease in Bax expression within the
liver tissues (arrow). Scale bar = 100 µm. (B): Statistical analysis of Bax H-score. Data are expressed as
mean ± SD. Significantly (### p < 0.001) different to negative control group. Significantly (*** p < 0.001)
different to the CCl4 group.
Figure 6 revealed that CCl4 significantly (p < 0.01) declined the expression level of Bcl-2 in liver
tissues compared to those in the control group. Treatment with either low or high dose of the flavone
can elevate the declined Bcl-2 levels. The flavone at concentration of 25 mg/kg significantly (p < 0.01)
increased the declined expression of Bcl-2, with value more than that recorded in the other groups.
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2.5. TGF-β1 Protein Levels in the Liver Tissue
As displayed in Figure 7, the administration of CCl4 caused a significant (p < 0.01) elevation
in TGF-β1 levels compared to control group. Treatment with flavone restored the protein levels of
TGF-β1. In particular, the high dose of flavone (25 mg/kg) significantly (p < 0.01) decreased the TGF-β1
level compared to the CCl4 model group.
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2.6. CD31 Protein Levels in the Liver Tissue
Compared to the negative control group, the CD31 protein level was significantly (p < 0.001)
augmented in liver tissues due to the action of CCl4 administration. In contrast, CD31 levels declined
in CCl4 model control group after the treatment with the flavone. The high dose of the flavone
significantly (p < 0.001) reduced the CD31 level, compared to that detected in the CCl4 group (Figure 8).
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3. Discussion
Based on the fact that oxidative stress, apoptosis and angiogenesis mechanisms exhibited desirable
effects for treatment of liver diseases in animal models, and to be clinically effective in preventing
the disease progress or improving the outcome of patients [13–16]. Additionally, the in vivo model
of CCl4-induced liver injury possesses a parallel molecular mechanism with chemical liver injury in
humans [37]. Therefore, the current study aimed to investigate the in vivo protective effect of the
flavone and its possible mechanisms in liver injury through studying its anti-antioxidant, anti-apoptotic,
and anti-angiogenic activities in a mouse model of CCl4-induced liver injuries.
Hematoxylin and eosin (H&E) staining of the liver sections from CCl4 group showed multifocal
granuloma like lesions within the whole hepatic parenchyma which consisted from mononuclear
inflammatory cells infiltration mainly macrophage and lymphocytes mixed with multiple neoplastic
cells. The outcome results were comparable to the previously reported histopathological examinations
of liver injuries induced by CCl4 in mice [38–40]. On the other hand, compared to the CCl4 model
group, hepatocytes were found to be normalized with minimum cellular necrosis after the flavone
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treatments, especially at 25 mg/kg, suggesting that the flavone was able to improve liver toxicity and
histopathological changes produced by CCl4 in mice.
Lipid peroxide is a primary parameter which can be considered as a marker of oxidative injury,
and hepatic MDA formation is commonly used as an indicator of liver tissue damage involving a
series of chain reactions [41]. An increase in MDA levels in the liver suggested the enhancement
of oxidative stress leading to tissue damage and failure of the antioxidant defense mechanisms to
prevent the formation of excessive free radicals [42]. The results of the current study revealed marked
increase in liver MDA levels in the liver tissue homogenate in CCl4-injected mice compared to the
untreated normal mice. This result is consistent with previously reported studies [2,43–45]. On the
other hand, the elevated hepatic MDA levels were significantly decreased by administration of the
flavone. Therefore, we suggest that flavone exhibited protective effects against CCl4-induced liver
damage in terms of preventing lipid peroxide formation and blocking oxidative chain reactions leading
to decrease the lipid peroxidation and consequently reduce MDA levels in liver tissues.
Oxidative stress is produced due to the imbalance of cellular oxidation production and antioxidant
capability. Therefore, it has become an attractive therapeutic strategy of antioxidant supplementation
for reducing the risk of liver disease induced by superfluous free radicals [46,47]. SOD decrease the
concentration of highly reactive superoxide radicals by transforming them to H2O2, while catalase
(CAT), glutathione (GSH), and glutathione peroxidase (GPx) degrade H2O2 to protect the liver tissue
from ROS produced by CCl4 exposure [48,49]. In our experiments, we found that administration of
CCl4 to mice decreased the antioxidant capacity of mouse liver as evidenced by the declined levels of
SOD, CAT and GPx, which were in agreement with the earlier results [50–52]. On the other hand, the
treatment with the flavone significantly increased the reduced levels of antioxidant enzymes, especially
at the high dosage of 25 mg/kg, suggesting that the flavone could protect liver against oxidative stress
in CCl4-damaged mice via neutralizing the oxidative activity of CCl4-induced free radicals in the
liver tissue.
Apoptosis is mediated by caspases upregulation, a class of cysteine proteins that cleave hundreds
of various proteins. The antiapoptotic Bcl-2 protein inhibits apoptosis through the inhibition of
pro-apoptosis protein BAX [53,54]. Our current results showed the decline of the Bcl-2 protein level
in CCl4 model group compared to untreatd control group. Furthermore, in order to additionally
understand the pathways of the anti-apoptotic effect of the flavone in CCl4-induced liver damage,
caspase-3 and Bax protein levels were measured in the liver samples. Caspase-3 and Bax protein levels
were significantly increased in the CCl4-injured liver tissues of mice compared to the untreated mice.
Our findings were consistent with the previous studies where CCl4 increases Bax expression as well
as caspase-3 regulation and reduces Bcl-2 protein expression demonstrating the induction of liver
cell apoptosis [55,56]. On the other hand, the flavone exhibited antiapoptotic activity towards CCl4
induced apoptosis via the reduction of Bcl-2 levels and decline of the elevated levels of Bax as well
as caspase-3.
TGF-β is an essential regulator of homeostasis in the liver tissue and its alteration attributes to
liver damage and even hepatocellular carcinoma. Injured liver potentiates the increase of TGF-β1
levels participating in the cell death cascade [57]. Our results showed that the levels of TGF-β1 were
significantly increased in the liver tissues of mice treated with CCl4. This finding is consistent with the
previous studies reporting the increase of TGF-β1 in the serum of mice treated with CCl4 [58] and in
hepatic tissue homogenate of acute liver injury [59]. Additionally, the regulation of the TGF-β1/Smad
signaling pathway is a new strategy employed in the prevention of liver fibrosis, and plays vital roles
during the processes of hepatocyte survival/restoration [60]. The flavone treatment markedly reduced
the elevated TGF-β1 protein to a level similar to the untreated control group.
CD31 (also known as platelet-endothelial cell adhesion molecule-1, PECAM-1) is identified as
a marker used for endothelial cells. It is expressed by the newly formed hepatic vasculature and
its level reflected the condition of angiogenesis [61]. Additionally, CD31 is found and expressed
on the surface of platelets and leukocytes and involved in endothelial cell junction, mediation of
Int. J. Mol. Sci. 2019, 20, 5215 11 of 16
leukocyte transmigration between endothelial cells and binding of platelets to injured endothelium [62].
Moreover, CD31 participates in the removal of apoptotic leukocytes and aged neutrophils through
promoting the tight binding of apoptotic cells with macrophage hence facilitate macrophage ingestion
of dying cells [63].
Angiogenesis develops in parallel with liver injury and fibrogenesis [64–66]. To investigate
the effect of the flavone on angiogenesis, we used CD31 as a marker for endothelial cells growth
and development. Our immunohistochemical staining results showed an increased CD31 protein
expression level in CCl4 model group compared to the control group. This was compatible with
the literature where an increase in the expression levels of CD31 was noticed in mice injected with
CCl4 [61,67]. The flavone decreased the elevated expression of CD31 and effectively attenuated liver
injury induced by CCl4. Moreover, it has been stated that CD31 is promoting liver cell apoptosis [68],
therefore, the ability of the flavone to inhibit hepatocytes apotosis and consequently reduce the over
expression of CD31 is a promising finding.
Taken together, it was evidential from our findings that the treatment with the flavone can
inhibit ROS formation, apoptosis and angiogenesis, secondary to hepatocytes damage in mice injected
with CCl4. The process was explained by the observed inhibition of lipid peroxidation, activation of
antioxidant enzymes, down-regulation of caspase-3 and Bax, increase the expression level of Bcl-2, and
decrease the expression levels of TGF-β1 and CD31.
4. Materials and Methods
4.1. Extraction, Isolation and Elucidation of Flavone
The dried and ground plant material (1.8 kg) of aerial parts of Tamarix aphylla L. was extracted
using a Soxhlet apparatus with 80% EtOH: H2O at 70–80 ◦C. The extract was concentrated in vacuo
at 45 ◦C and freeze dried for 8 h to afford 300 g of a semi-solid dark material. The crude extract
was suspended in distilled H2O and then successively partitioned between n-hexane, DCM, EtOAc,
n-BuOH, and H2O to generate the corresponding sub-extracts. The DCM sub-extract (20 g) was
loaded onto a normal-phase silica (NPS) gel column (70 × 5.6 cm) and eluted with gradients of MeOH:
DCM. The compound, 5-dihydroxy-4′,7-dimethoxyflavone, was isolated from the DCM extract. The
structure of the compound was established by chemical and spectral analysis, mainly MS (Nano
ACQUITY UPLC, Uppsala, Sweden), UV (Shimadzu UV-160A, Tokyo, Japan) and 1H-NMR (Bruker
DRX 400 spectrometer, Uppsala, Sweden). Recycling preparative HPLC (RP-HPLC (JAI LC-908W,
Japan Analytical Industry Co. Ltd., Tokyo, Japan) with a YMC ODS H-80 or L-80 column (“YMC,
Tokyo, Japan”) was used for the final purification of the flavone.
4.2. Animals
The protocol of the current study was approved by the Ethical Committee (26-8-2018) for
Laboratory Animals of Science Faculty Menoufia University (No.: ECLA-SFMU-26818). A total of 32
adult Swiss albino male mice (7–8 weeks old) with an average body weight of 25 g were used in the
current study. Mice were maintained in standard cages under controlled temperature conditions with
a 12 h light/dark cycle and given food and water ad libitum.
4.3. Liver Injury Induction and Experimental Design
Liver injury was induced in mice by intraperitoneal (i.p.) administration of CCl4 (0.4 mL/kg)
mixed in olive oil at ratio (1:4) twice a week for 6 consecutive weeks [69]. All mice groups were injected
with CCl4 except group 1 (normal control); mice i.p. administrated olive oil twice a week for six
consecutive weeks. After liver injury induction, mice were divided into three groups of 8 mice each as
follows: Group 2 (CCl4 model group); mice injected with CCl4 and i.p. treated with olive oil. Group 3;
mice injected with CCl4 and i.p. treated with the flavone at dose 10 mg/kg. Group 4; mice injected with
CCl4 and i.p. treated with the flavone at dose 25 mg/kg. The treatment with the flavone was for twice
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a week for 4 consecutive weeks. Both doses (10 and 25 mg/kg) were selected according to a lethal dose
study (data not shown). After the treatment period, mice were anaesthetized and sacrificed. Liver
tissues were removed, and the left lobes of the liver tissues were immediately fixed in 10% neutral
buffered formalin for histological and immunohistochemical examinations while the right lobes were
used to prepare liver homogenates.
4.4. Histological Examination
The histological examination of liver was performed using 10% formaldehyde for fixation then
liver tissues were embedded in paraffin wax and cut into sections with 5 µm thickness. Afterward,
sections were caught with glass slide and stained with H&E. The slides were examined under a light
microscope [70].
4.5. Estimation of Malondialdehyde (MDA) Level in Liver Homogenates
The 10% Liver homogenates were prepared with cold potassium phosphate buffer (50 mM, pH
7.4). The resulting suspension was centrifuged at 2000 rpm for 10 min. The supernatants were collected
for further analysis. All treatments were done at 4 ◦C. The effect of flavone on MDA levels were
determined as previously reported [34].
4.6. Determination of Anti-Oxidant Enzymes Levels in Liver Homogenates
The anti-oxidant activity of the flavone was determined through determination its effect on SOD,
CAT and GPx levels in liver homogenates. The levels of the enzymes were determined by commercial
kits according to the manufacturer’s instructions as previously reported [34].
4.7. Immunohistochemical Examination of Apoptosis and Angiogenesis-Related Protein Markers
The effect of the flavone on the protein expression levels of apoptosis-associated markers (Bax,
Bcl-2, caspase-3) and angiogenesis-associated markers (CD31, and TGF-β1) was estimated using
immunohistochemical assay as previously described [34]. In details, paraffin sections (5 µm) were
dewaxed in xylene and rehydrated in graded alcohol. Antigen retrieval was achieved using microwave
heating (20 min; 10 mmol/citrate buffer, pH 6). To block endogenous peroxidase activity, the sections
were immersed in H2O2 (0.3%) for 30 min, followed by blocking with 5% non-fat dry milk for 30 min.
The sections were incubated with primary monoclonal mouse anti-Bax, anti-Bcl-2, anti-Caspase-3,
anti-CD31, and anti-TGF-β1 (BioGenex, Fremont, CA, USA) overnight at room temperature (RT)
followed by three times washing with PBS (pH 7.4) for 5 min each. Sections were then incubated
with a secondary horseradish peroxidase (HRP)-conjugated anti-mouse antibody for 30 min at RT and
then developed by diaminobenzidine (DAB). The sections were stained with hematoxylin for 5 min.
H-scores of Bax, Bcl-2, caspase-3, CD31, and TGF-β1were evaluated using a light microscope. H-score
= ΣPi (i + 1), where i is the intensity of staining with a value of 1, 2 or 3 (weak, moderate or strong,
respectively), and where Pi is the percentage of stained cells for each intensity, varying from 0 to 100%.
4.8. Statistical Analysis
The results were expressed as mean ± standard deviation (SD). The statistical significance was
assessed by the Student’s t-test for comparisons of two groups, and one-way analysis of variance
(ANOVA) followed by Tukey’s post-hoc test for multiple group comparisons, using GraphPad
Prism 6 (GraphPad Software Inc., San Diego, CA, USA). A p value of < 0.05 was considered
statistically significant.
5. Conclusions, Limitations and Future Research
The present study demonstrated that 3,5-dihydroxy-4′,7-dimethoxyflavone could be a helpful
agent for the treatment of chemical-derived liver injury. The flavone exerted potentially protective
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antioxidant effects by increasing SOD, GPx, and CAT activities and decreasing lipid peroxidation. Also,
the flavone exhibited anti-apoptotic effects by increasing Bcl-2 level and down-regulation of caspase-3
and Bax. Moreover, the flavone decreased the expression levels of TGF-β1 and CD31.
In despite of, this is the first investigation with clear evidence that the flavone may be a potential
new complementary agent for the treatment of liver injury via the inhibition of ROS formation,
apoptosis and angiogenesis. The current study has limitations about the beneficial anti-inflammatory
activities of the flavone towards mouse model induced by CCl4. Therefore, future investigations are
appreciated to more thoroughly reveal the effects of the flavone on different inflammatory cytokines.
In particular, it would be of great interest to investigate whether the administration of flavone can
represent an effective treatment against inflammation that induced in the mice livers due to the action of
CCl4. Consequently, another study entitled “Differential cytokines expressions in liver tissue exposed
to CCl4 in response to flavone from Tamarix aphylla” will cover the examination of the activity of the
flavone on different inflammatory cytokines expressions such as TNF-α, IL-1α, IL-1β, IL-10 and IL-6.
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